Skip to main content

Table 1 Baseline subject characteristics

From: Supervised neuromuscular exercise prior to hip and knee replacement: 12-month clinical effect and cost-utility analysis alongside a randomised controlled trial

  Intervention group Control group  
  Mean difference (95%CI)
n 84 81  
Female sex 47 (56%) 45 (56%)  
Age–years 67.9 (8.6) 66.9 (8.3) 1.08 (−1.52 to 3.67)
BMI–kg/m2 29.6 (4.5) 31.1 (6.1) −1.41 (−3.05 to 0.24)
Waiting list THA 43 (51%) 41 (51%)  
Waiting list TKA 41 (49%) 40 (49%)  
EQ-5D-3L 0.63 (0.15) 0.57 (0.19) 0.06 (0.01 to 0.12)
HOOS/KOOS
  ADL 50.5 (15.1) 45.6 (16.9) 4.9 (−0.02 to 9.83)
Pain 46.8 (14.3) 42.7 (14.4) 4.0 (−0.39 to 8.46)
Symptoms 49.4 (19.7) 44.6 (18.6) 4.8 (−0.98 to 10.55)
Sport & Recreation 24.6 (17.2) 19.9 (18.2) 4.6 (−0.80 to 10.09)
Quality of life 31.2 (12.1) 28.9 (15.9) 2.3 (−2.01 to 6.60)
  1. Continuous variables are expressed as the mean (SD); non-continuous variables are expressed as the number of patients (%); THA, Total hip arthroplasy; TKA, Total knee arthroplasty; EQ5D-3L, European Quality of Life 5 Dimension 3 Level Health Outcome; HOOS, Hip disability and Osteoarthritis Outcome Score; KOOS, Knee injury and Osteoarthritis Outcome Score; ADL, function in daily living